Annual SG&A
$5.45 M
+$972.40 K+21.71%
31 December 2023
Summary:
Oragenics annual selling, general & administrative expenses is currently $5.45 million, with the most recent change of +$972.40 thousand (+21.71%) on 31 December 2023. During the last 3 years, it has risen by +$180.10 thousand (+3.42%). OGEN annual SG&A is now -27.69% below its all-time high of $7.54 million, reached on 31 December 2013.OGEN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.56 M
+$159.00 K+11.36%
30 September 2024
Summary:
Oragenics quarterly selling, general & administrative expenses is currently $1.56 million, with the most recent change of +$159.00 thousand (+11.36%) on 30 September 2024. Over the past year, it has dropped by -$196.10 thousand (-11.18%). OGEN quarterly SG&A is now -39.09% below its all-time high of $2.56 million, reached on 30 September 2013.OGEN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$839.30 M
-$19.97 M-2.44%
30 September 2024
Summary:
Oragenics TTM selling, general & administrative expenses is currently -$839.30 million, with the most recent change of -$19.97 million (-2.44%) on 30 September 2024. Over the past year, it has dropped by -$844.75 million (-15494.33%). OGEN TTM SG&A is now -61167.14% below its all-time high of $7.54 million, reached on 31 December 2013.OGEN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -11.2% | -10000.0% |
| 3 y3 years | +3.4% | +44.6% | -10000.0% |
| 5 y5 years | +45.1% | +73.5% | -10000.0% |
OGEN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +21.7% | -13.3% | +75.6% | -26.1% | at low |
| 5 y | 5 years | at high | +45.1% | -21.2% | +92.8% | -72.7% | at low |
| alltime | all time | -27.7% | +638.1% | -39.1% | +1441.3% | <-9999.0% | at low |
Oragenics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.56 M(+11.4%) | $6.51 M(+3.6%) |
| June 2024 | - | $1.40 M(-22.1%) | $6.28 M(+4.7%) |
| Mar 2024 | - | $1.80 M(+2.4%) | $6.00 M(+10.0%) |
| Dec 2023 | $5.45 M(+21.7%) | $1.75 M(+31.6%) | $5.45 M(+18.9%) |
| Sept 2023 | - | $1.33 M(+19.4%) | $4.58 M(+2.6%) |
| June 2023 | - | $1.12 M(-10.7%) | $4.47 M(+1.6%) |
| Mar 2023 | - | $1.25 M(+40.8%) | $4.40 M(-1.8%) |
| Dec 2022 | $4.48 M(-15.0%) | $887.20 K(-27.0%) | $4.48 M(-4.1%) |
| Sept 2022 | - | $1.22 M(+16.4%) | $4.67 M(+8.6%) |
| June 2022 | - | $1.04 M(-21.6%) | $4.30 M(-7.0%) |
| Mar 2022 | - | $1.33 M(+23.5%) | $4.63 M(-12.2%) |
| Dec 2021 | $5.27 M(+16.3%) | $1.08 M(+27.2%) | $5.27 M(-2.2%) |
| Sept 2021 | - | $847.10 K(-38.2%) | $5.39 M(-2.9%) |
| June 2021 | - | $1.37 M(-30.7%) | $5.55 M(+11.3%) |
| Mar 2021 | - | $1.98 M(+65.2%) | $4.99 M(+10.1%) |
| Dec 2020 | $4.53 M(+20.7%) | $1.20 M(+18.5%) | $4.53 M(+7.0%) |
| Sept 2020 | - | $1.01 M(+25.0%) | $4.24 M(+3.9%) |
| June 2020 | - | $808.30 K(-46.8%) | $4.08 M(-5.1%) |
| Mar 2020 | - | $1.52 M(+69.1%) | $4.30 M(+14.3%) |
| Dec 2019 | $3.76 M(-6.6%) | $898.30 K(+5.3%) | $3.76 M(-3.4%) |
| Sept 2019 | - | $852.80 K(-16.9%) | $3.89 M(-7.8%) |
| June 2019 | - | $1.03 M(+4.6%) | $4.22 M(+0.3%) |
| Mar 2019 | - | $980.40 K(-4.9%) | $4.21 M(+4.6%) |
| Dec 2018 | $4.02 M(+26.5%) | $1.03 M(-12.9%) | $4.02 M(+12.1%) |
| Sept 2018 | - | $1.18 M(+17.0%) | $3.59 M(+7.8%) |
| June 2018 | - | $1.01 M(+27.2%) | $3.33 M(+7.1%) |
| Mar 2018 | - | $795.50 K(+33.2%) | $3.11 M(-2.2%) |
| Dec 2017 | $3.18 M(-16.1%) | $597.10 K(-35.4%) | $3.18 M(-9.5%) |
| Sept 2017 | - | $925.00 K(+16.9%) | $3.51 M(-4.8%) |
| June 2017 | - | $791.30 K(-8.5%) | $3.69 M(-3.9%) |
| Mar 2017 | - | $865.20 K(-7.2%) | $3.84 M(+0.4%) |
| Dec 2016 | $3.79 M(+24.3%) | $932.00 K(-15.4%) | $3.82 M(+2.1%) |
| Sept 2016 | - | $1.10 M(+17.1%) | $3.75 M(+10.0%) |
| June 2016 | - | $940.60 K(+10.7%) | $3.41 M(+6.5%) |
| Mar 2016 | - | $849.80 K(-0.6%) | $3.20 M(+1.1%) |
| Dec 2015 | $3.05 M(-8.3%) | $854.90 K(+12.2%) | $3.16 M(+1.4%) |
| Sept 2015 | - | $761.90 K(+4.0%) | $3.12 M(+6.7%) |
| June 2015 | - | $732.30 K(-10.2%) | $2.92 M(-13.2%) |
| Mar 2015 | - | $815.50 K(+0.4%) | $3.37 M(+1.4%) |
| Dec 2014 | $3.32 M(-55.9%) | $811.90 K(+43.7%) | $3.32 M(-31.8%) |
| Sept 2014 | - | $565.10 K(-52.0%) | $4.87 M(-29.0%) |
| June 2014 | - | $1.18 M(+53.4%) | $6.86 M(-4.7%) |
| Mar 2014 | - | $767.40 K(-67.5%) | $7.20 M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $7.54 M(+50.1%) | $2.36 M(-7.8%) | $7.54 M(+16.6%) |
| Sept 2013 | - | $2.56 M(+68.4%) | $6.47 M(+17.5%) |
| June 2013 | - | $1.52 M(+37.7%) | $5.50 M(+14.2%) |
| Mar 2013 | - | $1.10 M(-14.1%) | $4.82 M(-4.1%) |
| Dec 2012 | $5.02 M(-10.7%) | $1.28 M(-19.5%) | $5.02 M(+1.4%) |
| Sept 2012 | - | $1.60 M(+91.1%) | $4.95 M(+4.9%) |
| June 2012 | - | $835.50 K(-36.1%) | $4.72 M(-15.3%) |
| Mar 2012 | - | $1.31 M(+7.7%) | $5.58 M(-0.9%) |
| Dec 2011 | $5.63 M(-10.5%) | $1.21 M(-11.0%) | $5.63 M(-4.7%) |
| Sept 2011 | - | $1.36 M(-19.4%) | $5.91 M(-4.2%) |
| June 2011 | - | $1.69 M(+24.6%) | $6.17 M(-0.5%) |
| Mar 2011 | - | $1.36 M(-9.1%) | $6.20 M(-1.4%) |
| Dec 2010 | $6.29 M(+27.8%) | $1.49 M(-8.1%) | $6.29 M(+7.9%) |
| Sept 2010 | - | $1.62 M(-5.6%) | $5.83 M(+8.5%) |
| June 2010 | - | $1.72 M(+19.0%) | $5.37 M(+10.5%) |
| Mar 2010 | - | $1.45 M(+39.9%) | $4.86 M(-1.2%) |
| Dec 2009 | $4.92 M(+14.0%) | $1.03 M(-11.3%) | $4.92 M(-22.9%) |
| Sept 2009 | - | $1.17 M(-3.7%) | $6.38 M(+7.0%) |
| June 2009 | - | $1.21 M(-19.7%) | $5.96 M(+11.0%) |
| Mar 2009 | - | $1.51 M(-39.6%) | $5.37 M(+24.6%) |
| Dec 2008 | $4.31 M(+377.7%) | $2.50 M(+233.0%) | $4.31 M(+107.9%) |
| Sept 2008 | - | $749.50 K(+21.1%) | $2.07 M(+35.6%) |
| June 2008 | - | $618.90 K(+38.2%) | $1.53 M(+35.1%) |
| Mar 2008 | - | $447.70 K(+73.6%) | $1.13 M(+25.5%) |
| Dec 2007 | $902.70 K(-10.1%) | $257.90 K(+25.6%) | $902.60 K(+18.5%) |
| Sept 2007 | - | $205.30 K(-7.4%) | $761.70 K(-1.8%) |
| June 2007 | - | $221.60 K(+1.7%) | $775.80 K(-9.5%) |
| Mar 2007 | - | $217.80 K(+86.2%) | $857.10 K(-14.6%) |
| Dec 2006 | $1.00 M(-14.0%) | $117.00 K(-46.7%) | $1.00 M(-15.9%) |
| Sept 2006 | - | $219.40 K(-27.6%) | $1.19 M(-4.1%) |
| June 2006 | - | $302.90 K(-17.0%) | $1.25 M(-4.2%) |
| Mar 2006 | - | $364.80 K(+18.8%) | $1.30 M(+11.4%) |
| Dec 2005 | $1.17 M(-12.3%) | $307.20 K(+13.6%) | $1.17 M(-18.1%) |
| Sept 2005 | - | $270.50 K(-24.3%) | $1.42 M(+7.0%) |
| June 2005 | - | $357.20 K(+54.0%) | $1.33 M(+4.1%) |
| Mar 2005 | - | $231.90 K(-59.0%) | $1.28 M(-3.8%) |
| Dec 2004 | $1.33 M(+80.1%) | $565.20 K(+217.9%) | $1.33 M(+25.4%) |
| Sept 2004 | - | $177.80 K(-41.7%) | $1.06 M(-1.4%) |
| June 2004 | - | $304.80 K(+8.0%) | $1.08 M(+17.0%) |
| Mar 2004 | - | $282.20 K(-4.7%) | $919.70 K(+24.5%) |
| Dec 2003 | $738.60 K | $296.00 K(+53.5%) | $738.60 K(+66.9%) |
| Sept 2003 | - | $192.80 K(+29.7%) | $442.60 K(+77.2%) |
| June 2003 | - | $148.70 K(+47.1%) | $249.80 K(+147.1%) |
| Mar 2003 | - | $101.10 K | $101.10 K |
FAQ
- What is Oragenics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Oragenics?
- What is Oragenics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Oragenics?
- What is Oragenics quarterly SG&A year-on-year change?
- What is Oragenics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Oragenics?
- What is Oragenics TTM SG&A year-on-year change?
What is Oragenics annual selling, general & administrative expenses?
The current annual SG&A of OGEN is $5.45 M
What is the all time high annual SG&A for Oragenics?
Oragenics all-time high annual selling, general & administrative expenses is $7.54 M
What is Oragenics quarterly selling, general & administrative expenses?
The current quarterly SG&A of OGEN is $1.56 M
What is the all time high quarterly SG&A for Oragenics?
Oragenics all-time high quarterly selling, general & administrative expenses is $2.56 M
What is Oragenics quarterly SG&A year-on-year change?
Over the past year, OGEN quarterly selling, general & administrative expenses has changed by -$196.10 K (-11.18%)
What is Oragenics TTM selling, general & administrative expenses?
The current TTM SG&A of OGEN is -$839.30 M
What is the all time high TTM SG&A for Oragenics?
Oragenics all-time high TTM selling, general & administrative expenses is $7.54 M
What is Oragenics TTM SG&A year-on-year change?
Over the past year, OGEN TTM selling, general & administrative expenses has changed by -$844.75 M (-15494.33%)